A deepening natural gas crisis in Bangladesh is severely disrupting domestic manufacturing, with production of paracetamol Active Pharmaceutical Ingredients (API) significantly curtailed.
The energy shortage is spreading beyond the pharmaceutical sector, causing widespread operational disruptions at factories across the country's industrial base.
The supply squeeze highlights the vulnerability of energy-intensive industries in the region to gas availability.
As domestic production of essential medical ingredients falls, local manufacturers face immediate capacity constraints that could impact supply chains for generic medicines.
The disruption extends to broader manufacturing, where gas-dependent facilities are scaling back output due to unreliable supply.
This development adds to regional energy stress, following reports that Indian natural gas companies are also facing procurement challenges and rising costs linked to supply chain disruptions in West Asia.